0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell and Gene Therapy Solutions Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-35R14248
Home | Market Reports | Health| Health Conditions
Global Cell and Gene Therapy Solutions Market Research Report 2023
BUY CHAPTERS

Global Cell and Gene Therapy Solutions Market Research Report 2025

Code: QYRE-Auto-35R14248
Report
February 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell and Gene Therapy Solutions Market

The global market for Cell and Gene Therapy Solutions was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cell & gene therapies are used to treat both rare and common diseases. While gene therapy involves the transfer of genetic material, usually within a virus for uptake into diseased cells, cell therapy involves the transfer of genetically altered cells into a patient.
The field of cell and gene therapy is currently in a phase of robust growth, with an expanding market size. As scientific advancements continue, the application scope of cell and gene therapies is widening, encompassing the treatment of various diseases such as cancer, genetic disorders, and autoimmune conditions. Sales within this sector are on a consistent upward trajectory, reflecting significant commercial potential. While some remarkable successes have been achieved in the realm of cell and gene therapy, challenges concerning safety and regulatory compliance persist. Looking ahead, as research deepens, it is anticipated that the field will continue to make breakthroughs, ushering in more innovation and transformative changes within the medical domain.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Solutions.
The Cell and Gene Therapy Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell and Gene Therapy Solutions Market Report

Report Metric Details
Report Name Cell and Gene Therapy Solutions Market
Segment by Type
  • Stem Cell Therapy
  • Gene Therapy
  • Other
Segment by Application
  • Neurological Diseases
  • Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bluebird Bio, Sarepta Therapeutics, Solid Biosciences, Novartis, Biomarin Pharmaceutical, Uniqure, Spark Therapeutics, Alaunos Therapeutics, Homology Medicines, Biogen, Legend Biotech, CARsgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell and Gene Therapy Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell and Gene Therapy Solutions Market report?

Ans: The main players in the Cell and Gene Therapy Solutions Market are Bluebird Bio, Sarepta Therapeutics, Solid Biosciences, Novartis, Biomarin Pharmaceutical, Uniqure, Spark Therapeutics, Alaunos Therapeutics, Homology Medicines, Biogen, Legend Biotech, CARsgen

What are the Application segmentation covered in the Cell and Gene Therapy Solutions Market report?

Ans: The Applications covered in the Cell and Gene Therapy Solutions Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Cell and Gene Therapy Solutions Market report?

Ans: The Types covered in the Cell and Gene Therapy Solutions Market report are Stem Cell Therapy, Gene Therapy, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Therapy
1.2.3 Gene Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Solutions Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Solutions Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Solutions Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Solutions Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Solutions Market Dynamics
2.3.1 Cell and Gene Therapy Solutions Industry Trends
2.3.2 Cell and Gene Therapy Solutions Market Drivers
2.3.3 Cell and Gene Therapy Solutions Market Challenges
2.3.4 Cell and Gene Therapy Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Solutions Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Solutions Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Solutions Revenue
3.4 Global Cell and Gene Therapy Solutions Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Solutions Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Solutions Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Solutions, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Solutions Breakdown Data by Type
4.1 Global Cell and Gene Therapy Solutions Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Solutions Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Solutions Breakdown Data by Application
5.1 Global Cell and Gene Therapy Solutions Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Solutions Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Solutions Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Solutions Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Solutions Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Solutions Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Solutions Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Solutions Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Solutions Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Cell and Gene Therapy Solutions Introduction
11.1.4 Bluebird Bio Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.1.5 Bluebird Bio Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Cell and Gene Therapy Solutions Introduction
11.2.4 Sarepta Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Solid Biosciences
11.3.1 Solid Biosciences Company Details
11.3.2 Solid Biosciences Business Overview
11.3.3 Solid Biosciences Cell and Gene Therapy Solutions Introduction
11.3.4 Solid Biosciences Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.3.5 Solid Biosciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cell and Gene Therapy Solutions Introduction
11.4.4 Novartis Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Biomarin Pharmaceutical
11.5.1 Biomarin Pharmaceutical Company Details
11.5.2 Biomarin Pharmaceutical Business Overview
11.5.3 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Introduction
11.5.4 Biomarin Pharmaceutical Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.5.5 Biomarin Pharmaceutical Recent Development
11.6 Uniqure
11.6.1 Uniqure Company Details
11.6.2 Uniqure Business Overview
11.6.3 Uniqure Cell and Gene Therapy Solutions Introduction
11.6.4 Uniqure Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.6.5 Uniqure Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Cell and Gene Therapy Solutions Introduction
11.7.4 Spark Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.7.5 Spark Therapeutics Recent Development
11.8 Alaunos Therapeutics
11.8.1 Alaunos Therapeutics Company Details
11.8.2 Alaunos Therapeutics Business Overview
11.8.3 Alaunos Therapeutics Cell and Gene Therapy Solutions Introduction
11.8.4 Alaunos Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.8.5 Alaunos Therapeutics Recent Development
11.9 Homology Medicines
11.9.1 Homology Medicines Company Details
11.9.2 Homology Medicines Business Overview
11.9.3 Homology Medicines Cell and Gene Therapy Solutions Introduction
11.9.4 Homology Medicines Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.9.5 Homology Medicines Recent Development
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Cell and Gene Therapy Solutions Introduction
11.10.4 Biogen Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.10.5 Biogen Recent Development
11.11 Legend Biotech
11.11.1 Legend Biotech Company Details
11.11.2 Legend Biotech Business Overview
11.11.3 Legend Biotech Cell and Gene Therapy Solutions Introduction
11.11.4 Legend Biotech Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.11.5 Legend Biotech Recent Development
11.12 CARsgen
11.12.1 CARsgen Company Details
11.12.2 CARsgen Business Overview
11.12.3 CARsgen Cell and Gene Therapy Solutions Introduction
11.12.4 CARsgen Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.12.5 CARsgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell and Gene Therapy Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stem Cell Therapy
 Table 3. Key Players of Gene Therapy
 Table 4. Key Players of Other
 Table 5. Global Cell and Gene Therapy Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell and Gene Therapy Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cell and Gene Therapy Solutions Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cell and Gene Therapy Solutions Market Share by Region (2020-2025)
 Table 9. Global Cell and Gene Therapy Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cell and Gene Therapy Solutions Market Share by Region (2026-2031)
 Table 11. Cell and Gene Therapy Solutions Market Trends
 Table 12. Cell and Gene Therapy Solutions Market Drivers
 Table 13. Cell and Gene Therapy Solutions Market Challenges
 Table 14. Cell and Gene Therapy Solutions Market Restraints
 Table 15. Global Cell and Gene Therapy Solutions Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cell and Gene Therapy Solutions Market Share by Players (2020-2025)
 Table 17. Global Top Cell and Gene Therapy Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Solutions as of 2024)
 Table 18. Ranking of Global Top Cell and Gene Therapy Solutions Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Solutions Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cell and Gene Therapy Solutions, Headquarters and Area Served
 Table 21. Global Key Players of Cell and Gene Therapy Solutions, Product and Application
 Table 22. Global Key Players of Cell and Gene Therapy Solutions, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cell and Gene Therapy Solutions Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cell and Gene Therapy Solutions Revenue Market Share by Type (2020-2025)
 Table 26. Global Cell and Gene Therapy Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cell and Gene Therapy Solutions Revenue Market Share by Type (2026-2031)
 Table 28. Global Cell and Gene Therapy Solutions Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cell and Gene Therapy Solutions Revenue Market Share by Application (2020-2025)
 Table 30. Global Cell and Gene Therapy Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cell and Gene Therapy Solutions Revenue Market Share by Application (2026-2031)
 Table 32. North America Cell and Gene Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cell and Gene Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cell and Gene Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cell and Gene Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cell and Gene Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cell and Gene Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cell and Gene Therapy Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cell and Gene Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cell and Gene Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cell and Gene Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cell and Gene Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Bluebird Bio Company Details
 Table 48. Bluebird Bio Business Overview
 Table 49. Bluebird Bio Cell and Gene Therapy Solutions Product
 Table 50. Bluebird Bio Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 51. Bluebird Bio Recent Development
 Table 52. Sarepta Therapeutics Company Details
 Table 53. Sarepta Therapeutics Business Overview
 Table 54. Sarepta Therapeutics Cell and Gene Therapy Solutions Product
 Table 55. Sarepta Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 56. Sarepta Therapeutics Recent Development
 Table 57. Solid Biosciences Company Details
 Table 58. Solid Biosciences Business Overview
 Table 59. Solid Biosciences Cell and Gene Therapy Solutions Product
 Table 60. Solid Biosciences Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 61. Solid Biosciences Recent Development
 Table 62. Novartis Company Details
 Table 63. Novartis Business Overview
 Table 64. Novartis Cell and Gene Therapy Solutions Product
 Table 65. Novartis Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 66. Novartis Recent Development
 Table 67. Biomarin Pharmaceutical Company Details
 Table 68. Biomarin Pharmaceutical Business Overview
 Table 69. Biomarin Pharmaceutical Cell and Gene Therapy Solutions Product
 Table 70. Biomarin Pharmaceutical Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 71. Biomarin Pharmaceutical Recent Development
 Table 72. Uniqure Company Details
 Table 73. Uniqure Business Overview
 Table 74. Uniqure Cell and Gene Therapy Solutions Product
 Table 75. Uniqure Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 76. Uniqure Recent Development
 Table 77. Spark Therapeutics Company Details
 Table 78. Spark Therapeutics Business Overview
 Table 79. Spark Therapeutics Cell and Gene Therapy Solutions Product
 Table 80. Spark Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 81. Spark Therapeutics Recent Development
 Table 82. Alaunos Therapeutics Company Details
 Table 83. Alaunos Therapeutics Business Overview
 Table 84. Alaunos Therapeutics Cell and Gene Therapy Solutions Product
 Table 85. Alaunos Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 86. Alaunos Therapeutics Recent Development
 Table 87. Homology Medicines Company Details
 Table 88. Homology Medicines Business Overview
 Table 89. Homology Medicines Cell and Gene Therapy Solutions Product
 Table 90. Homology Medicines Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 91. Homology Medicines Recent Development
 Table 92. Biogen Company Details
 Table 93. Biogen Business Overview
 Table 94. Biogen Cell and Gene Therapy Solutions Product
 Table 95. Biogen Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 96. Biogen Recent Development
 Table 97. Legend Biotech Company Details
 Table 98. Legend Biotech Business Overview
 Table 99. Legend Biotech Cell and Gene Therapy Solutions Product
 Table 100. Legend Biotech Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 101. Legend Biotech Recent Development
 Table 102. CARsgen Company Details
 Table 103. CARsgen Business Overview
 Table 104. CARsgen Cell and Gene Therapy Solutions Product
 Table 105. CARsgen Revenue in Cell and Gene Therapy Solutions Business (2020-2025) & (US$ Million)
 Table 106. CARsgen Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Cell and Gene Therapy Solutions Picture
 Figure 2. Global Cell and Gene Therapy Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell and Gene Therapy Solutions Market Share by Type: 2024 VS 2031
 Figure 4. Stem Cell Therapy Features
 Figure 5. Gene Therapy Features
 Figure 6. Other Features
 Figure 7. Global Cell and Gene Therapy Solutions Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cell and Gene Therapy Solutions Market Share by Application: 2024 VS 2031
 Figure 9. Neurological Diseases Case Studies
 Figure 10. Cancer Case Studies
 Figure 11. Other Case Studies
 Figure 12. Cell and Gene Therapy Solutions Report Years Considered
 Figure 13. Global Cell and Gene Therapy Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Cell and Gene Therapy Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Cell and Gene Therapy Solutions Market Share by Region: 2024 VS 2031
 Figure 16. Global Cell and Gene Therapy Solutions Market Share by Players in 2024
 Figure 17. Global Top Cell and Gene Therapy Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Solutions as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Solutions Revenue in 2024
 Figure 19. North America Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Cell and Gene Therapy Solutions Market Share by Country (2020-2031)
 Figure 21. United States Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cell and Gene Therapy Solutions Market Share by Country (2020-2031)
 Figure 25. Germany Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cell and Gene Therapy Solutions Market Share by Region (2020-2031)
 Figure 33. China Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cell and Gene Therapy Solutions Market Share by Country (2020-2031)
 Figure 41. Mexico Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cell and Gene Therapy Solutions Market Share by Country (2020-2031)
 Figure 45. Turkey Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Cell and Gene Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Bluebird Bio Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 49. Sarepta Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 50. Solid Biosciences Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 52. Biomarin Pharmaceutical Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 53. Uniqure Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 54. Spark Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 55. Alaunos Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 56. Homology Medicines Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 57. Biogen Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 58. Legend Biotech Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 59. CARsgen Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart